| 2.6 |
7.7 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 2.4 |
7.1 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 2.2 |
42.2 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 2.1 |
10.3 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 2.0 |
6.0 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 1.8 |
5.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 1.5 |
4.4 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 1.4 |
4.2 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 1.4 |
4.1 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 1.4 |
10.9 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 1.3 |
9.2 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 1.3 |
3.8 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.2 |
3.6 |
GO:0002159 |
desmosome assembly(GO:0002159) adherens junction maintenance(GO:0034334) intermediate filament bundle assembly(GO:0045110) maintenance of organ identity(GO:0048496) |
| 1.2 |
4.7 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 1.1 |
3.3 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 1.1 |
4.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 1.0 |
6.0 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 1.0 |
3.0 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.9 |
3.8 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.9 |
3.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.9 |
4.3 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.9 |
9.5 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.8 |
2.4 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.8 |
5.7 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.8 |
0.8 |
GO:1904884 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.7 |
5.1 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.7 |
4.9 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.7 |
2.7 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.7 |
7.2 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.6 |
4.5 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.6 |
1.8 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.6 |
1.7 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.5 |
4.4 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.5 |
4.3 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.5 |
3.4 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.5 |
3.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.4 |
3.1 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.4 |
3.9 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.4 |
1.3 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.4 |
1.3 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.4 |
3.1 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.4 |
1.3 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) positive regulation of germinal center formation(GO:0002636) adenosine catabolic process(GO:0006154) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) purine nucleobase salvage(GO:0043096) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) xanthine metabolic process(GO:0046110) purine deoxyribonucleoside metabolic process(GO:0046122) negative regulation of mucus secretion(GO:0070256) |
| 0.4 |
2.5 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 |
25.6 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.4 |
1.6 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.4 |
7.6 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.4 |
7.5 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.4 |
1.9 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.4 |
3.8 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.4 |
2.6 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.4 |
1.8 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
1.4 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.3 |
1.0 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.3 |
2.7 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.3 |
2.4 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.3 |
17.2 |
GO:0035307 |
positive regulation of protein dephosphorylation(GO:0035307) |
| 0.3 |
1.6 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.3 |
0.9 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 |
1.9 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.3 |
2.2 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.3 |
4.0 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.3 |
12.9 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.3 |
1.9 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.3 |
5.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.2 |
5.2 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.2 |
8.5 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.2 |
2.2 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.2 |
9.9 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.2 |
6.4 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.2 |
1.4 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
1.2 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.2 |
1.8 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.2 |
2.8 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.2 |
1.1 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.2 |
2.6 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.2 |
1.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.2 |
1.9 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 |
8.7 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.2 |
7.0 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
1.2 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 |
1.0 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
2.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.9 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
1.8 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
11.0 |
GO:0007127 |
meiosis I(GO:0007127) |
| 0.1 |
1.0 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
13.8 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.1 |
1.3 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.4 |
GO:1904995 |
regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 |
0.4 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
2.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
1.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
2.4 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.1 |
0.3 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) flavin-containing compound metabolic process(GO:0042726) |
| 0.1 |
1.9 |
GO:0035337 |
fatty-acyl-CoA metabolic process(GO:0035337) |
| 0.1 |
1.9 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
5.6 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.1 |
8.0 |
GO:0007093 |
mitotic cell cycle checkpoint(GO:0007093) |
| 0.1 |
3.4 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
1.0 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
1.3 |
GO:0061050 |
regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.1 |
2.0 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
2.7 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
1.5 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.8 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.7 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
1.0 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
3.5 |
GO:0045843 |
negative regulation of striated muscle tissue development(GO:0045843) |
| 0.1 |
1.0 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.6 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
2.5 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
1.8 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.8 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
3.5 |
GO:0006687 |
glycosphingolipid metabolic process(GO:0006687) |
| 0.1 |
1.0 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
1.4 |
GO:0046500 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 |
0.6 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
5.1 |
GO:0042476 |
odontogenesis(GO:0042476) |
| 0.1 |
0.2 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
1.4 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
3.7 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 |
2.5 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
1.5 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
1.6 |
GO:0006760 |
folic acid-containing compound metabolic process(GO:0006760) |
| 0.1 |
1.0 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.1 |
0.3 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
5.4 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.1 |
1.2 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.1 |
1.2 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.1 |
0.9 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.0 |
0.7 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.0 |
0.5 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
13.7 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.6 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.4 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.2 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 |
0.0 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.0 |
4.3 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.0 |
0.3 |
GO:0071453 |
cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
| 0.0 |
2.1 |
GO:0061178 |
regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.0 |
0.4 |
GO:0060049 |
regulation of protein glycosylation(GO:0060049) |
| 0.0 |
0.6 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
0.2 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
0.4 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.7 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.0 |
1.5 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
0.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
4.9 |
GO:0007059 |
chromosome segregation(GO:0007059) |
| 0.0 |
0.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.0 |
0.9 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.0 |
0.8 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.4 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.2 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 |
0.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.6 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.2 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
1.1 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 |
0.3 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
0.8 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.4 |
GO:0031440 |
regulation of mRNA 3'-end processing(GO:0031440) |
| 0.0 |
1.9 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
2.9 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.0 |
0.1 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.0 |
0.1 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.0 |
0.8 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.6 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
